APA (7th ed.) Citation

Handke, A. E., Orf, C., Dellino, M., Garcia-Schürmann, L. M., Radtke, J. P., Noldus, J., . . . Tully, K. H. (2025). Upstaging of Patients Diagnosed with Favorable Intermediate-Risk Prostate Cancer—Is Active Surveillance Really a Suitable Approach for All These Patients? Cancers, 17(21), 3444. https://doi.org/10.3390/cancers17213444

Chicago Style (17th ed.) Citation

Handke, Analena E., et al. "Upstaging of Patients Diagnosed with Favorable Intermediate-Risk Prostate Cancer—Is Active Surveillance Really a Suitable Approach for All These Patients?" Cancers 17, no. 21 (2025): 3444. https://doi.org/10.3390/cancers17213444.

MLA (9th ed.) Citation

Handke, Analena E., et al. "Upstaging of Patients Diagnosed with Favorable Intermediate-Risk Prostate Cancer—Is Active Surveillance Really a Suitable Approach for All These Patients?" Cancers, vol. 17, no. 21, 2025, p. 3444, https://doi.org/10.3390/cancers17213444.